Volume 10, Issue 2

• Treatment of Paroxysmal Perceptual Alteration in Catatonic Schizophrenia by Switching to Aripiprazole from Risperidone: A Case Report
  Author(s): Satoko Yamashita, Tsuyoshi Miyaoka, Michiharu Nagahama, Masa Ieda, Keiko Tsuchie, Rei Wake, Jun Horiguchi
  • Abstract
  • PDF
• Social Stigma and Well-Being in a Sample of Schizophrenia Patients
  Author(s): Alejandro Magallares, Daniel Perez-Garin, Fernando Molero
  • Abstract
  • PDF
• A Case of RisperidoneInduced Priapism in a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency
  Author(s): Alanna J. Propst, G. Eric Jarvis, Howard C. Margolese
  • PDF
• Psychosocial Treatments for Schizophrenia: An Evaluation of Theoretically Divergent Treatment Paradigms, and Their Efficacy
  Author(s): Cameron M. Clark
  • Abstract
  • PDF
• Clinical News �?� antipsychotic updates �?� prodrome detection �?� first-episode schizophrenia management �?� brain inflammation �?� MRI brain �??fingerprint�?� �?� long-acting injectable antipsychotics �?� fish oil and schizophrenia �?� metformin for metabolic dysfunction �?� legacy through philanthropy �?�
  Author(s): Peter F. Buckley
  • PDF
• Aripiprazole Lauroxil Long-Acting Injectable: The Latest Addition to Second-Generation Long-Acting Agents
  Author(s): Arpit Aggarwal, Ganesh Gopalakrishna, John Lauriello
  • Abstract
  • PDF